Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA's Victoza Decision BalancedUnknown Cancer Risk Against Known FDAAA Measures
Feb 01 2010
•
By
Pharmaceutical Approvals Monthly
More from Archive
More from Pink Sheet